Notice Of Intent To Sole Source - Lateral Flow Assay Design Using Antibodies Developed By The Cdc To Detect Antiretroviral Drugs

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 81024840

  Document Type - Tender Notices

Description - NOTICE OF INTENT TO ISSUE AN ORDER.  This is not a request for competitive proposals/quotes. The Centers for Disease Control and Prevention (CDC) hereby announces its intent to issue a sole source order to NanoComposix, Inc. 4878 Ronson Ct., Suite J San Diego, CA for of the procurement of  Nanocomposix Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs The NAICS code for this acquisition is 541713 Research And Development In Nanotechnology ***** Subject to the Availability of Funds ***** Nanocomposix Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs ***** A determination by the Government not to compet

Gt Ref Id - 81024840

Deadline - Apr 26, 2024